First National Daily eMedical Newspaper of India
Nobody Reports News Better Than Us  
Editorial (Dr K K Aggarwal)                                                                                       (Dr RN Tandon)
We have improved our eMediNexus Platform with a far superior user experience.
Please click here to try it
9th December, 2017
To Err is Human: Post Mortem of the recent Max controversy

“A premature (22 weeks) newborn was allegedly declared dead. While being taken for the funeral, the newborn was discovered to be alive, put on life support system, and died after 5 days. His twin was stillborn.”

This was a ‘medical error’ caused due to wrong diagnosis and declaring a newborn dead in the presence of hypothermia. This amounts to professional incompetency and it is for the MCI or State Medical Council to take necessary action against the concerned doctors.
Clinical death vs permanent death is a concept that started after the introduction of CPR in the country. A similar mistake occurred in Safdarjung hospital in June 2017, that of terming clinical death as brain death. In clinical death, the person may have no signs of life, but the brain remains alive for 10 minutes in routine deaths and for few hours in hypothermia. CPR during this period can revive the heart.

To Read More or Comment, Click Here
Special
Top News

India, Cuba sign MoU for pharma regulation, medical devices

India and Cuba have signed a memorandum of understanding (MoU) to improve cooperation in the health sector such as regulation of pharmaceuticals, medical devices and information. The MoU was signed by Union Minister of Health and Family Welfare J.P. Nadda and his counterpart from Cuba, Roberto Tomas Morales Ojeda.... read more


MAX Hospital Cancelation Order

Max Super Specialty Hospital, Shalimar Bagh was initially registered under Delhi Nursing Homes Registration Act, 1953 on 05.09.2011 vide Registration No. 965 for 80 beds by the Supervising Authority under the said Act and the same was valid till 31.03.2014..... read more

Practice Updates
Pembrolizumab-trastuzumab active in Resistant HER2 Breast Cancer

A pilot study presented at the San Antonio Breast Cancer Symposium suggested that immunotherapy proved active in at least a subgroup of patients with metastatic, trastuzumab-resistant HER2-positive breast cancer. The combination of pembrolizumab and trastuzumab resulted in an objective response rate of 15% in patients with detectable levels of PD-L1 expression....read more


FDA Clears First Nebulized LAMA Inhaler for COPD

The US Food and Drug Administration (FDA) has approved glycopyrrolate inhalation solution 25 mcg twice daily for maintenance treatment of airflow obstruction in adults with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema...read more


Genetic Basis in Pediatric Peanut Allergies

Researchers from Mount Sinai have identified six genes involved in severe peanut allergies. These six genes activate hundreds of other genes in children who experience severe allergic reactions to peanuts. A study, published online in Nature Communications December 5, 2017,...read more


Lytic Therapy, Clot Removal in DVT Fail to Prevent Postthrombotic Syndrome

The risk of postthrombotic syndrome (PTS) was not found to decline significantly after treatment of proximal deep vein thrombosis (DVT) via catheter, using thrombolytic agents and thrombectomy or other invasive device measures when compared with anticoagulation therapy alone, suggested a new study published in the December 7, 2017...read more


Menarche Linked with Seizure Onset

Age at menarche is significantly associated with seizure onset age in epileptic women, suggests a study presented at the American Epilepsy Society annual meeting. The results point that seizure onset may be related to the entire puberty process....read more

 
eMedi Humor
Medicolegal Corner
eMedi Quiz
1. Succinyl CoA.
2. Propionyl CoA.
3. Acetyl CoA.
4. Malonyl CoA.
Lifestyle Updates
 
Inspirational Story 1: : Two Types of People
Inspirational Story 2: Look Fear in the Face
Viral hepatitis is a deadly condition
Hepatitis B and C cause the most fatal infections
 
New Delhi, 08 December 2017: About 1.5 lakh people die of hepatitis every year in India, as per reports and this condition affects 60 million people in the country. Viral hepatitis infection is also the leading cause of liver cancer and liver failure. Despite these alarming facts, only few people are aware of this condition that infects and kills more people in India than HIV, malaria and tuberculosis combined. There are five viral hepatitis strains of which hepatitis B and C cause the most fatal infections.
 
Hepatitis is an inflammation of the liver cells and damage to the liver. There are different types and causes, but the symptoms can be similar. The liver helps in detoxifying blood, storing vitamins, and producing hormones. Hepatitis can disrupt these processes and create severe health problems throughout the body.
To Read More or Comment, Click Here